We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Total laboratory-confirmed cases of measles in England and Wales.
Voluntary surveillance of streptococcal bacteraemia in England.
Data on trends in antimicrobial resistance and decreased susceptibility in gonococcal infection in England and Wales are provided by GRASP.
Counts and rates of MRSA, MSSA, E. coli, P. aeruginosa, Klebsiella spp. bacteraemia and C. difficile infection reported by independent sector healthcare organisations, with accompanying commentary.
The Joint Committee on Vaccination and Immunisation (JCVI) statement setting out its recommendation on a universal varicella (chickenpox) vaccination programme.
JCVI statement setting out advice on the use of the 4CMenB vaccine for the prevention of gonorrhoea in those who are at increased risk of infection.
Statement setting out the advice from JCVI on the use of the MVA-BN vaccination for the prevention of mpox.
Reports presenting 30-day all-cause mortality following infection with healthcare-associated infections (HCAI).
Interim public health and implementation evaluation of the first 12 months of the opt-out bloodborne virus testing in emergency departments programme in England.
Epidemiology, diagnosis, notification, surveillance, prevention and control of leprosy in the UK.
Monthly reports on non-COVID-19 laboratory confirmed respiratory infections in England and Wales.
HIV surveillance data in the UK by demographic characteristics and geographical region.
This rapid mapping review identifies and categorises evidence on the effectiveness of non-pharmaceutical interventions to reduce COVID-19 transmission.
Qualitative assessment of the risk Brucella canis presents to the UK public.
These reviews aim to identify and examine evidence on the effectiveness of face coverings to reduce transmission of COVID-19 in the community.
COMEAP summary of the science linking long-term air pollution exposure with SARS-CoV-2 infection and adverse COVID-19 outcomes.
Reports presenting data for sexually transmitted infections (STIs) in the West Midlands.
A review of the Vaccine Taskforce’s performance against its objectives, from establishment in April 2020 until closure in September 2022.
Technical briefing documents on coronavirus (COVID-19) therapeutic agents.
National monitoring tool that brings together metrics to assess the wider impacts of coronavirus (COVID-19) on health.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).